- Home
- SSY vs ADTX Comparison
SSY vs ADTX Comparison
Compare SSY & ADTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSY
- ADTX
- Stock Information
- Founded
- SSY 1959
- ADTX 2017
- Country
- SSY United States
- ADTX United States
- Employees
- SSY N/A
- ADTX N/A
- Industry
- SSY Hospital/Nursing Management
- ADTX Biotechnology: Pharmaceutical Preparations
- Sector
- SSY Health Care
- ADTX Health Care
- Exchange
- SSY Nasdaq
- ADTX Nasdaq
- Market Cap
- SSY 5.5M
- ADTX 5.3M
- IPO Year
- SSY N/A
- ADTX 2020
- Fundamental
- Price
- SSY $1.00
- ADTX $5.00
- Analyst Decision
- SSY
- ADTX
- Analyst Count
- SSY 0
- ADTX 0
- Target Price
- SSY N/A
- ADTX N/A
- AVG Volume (30 Days)
- SSY 32.0K
- ADTX 8.1M
- Earning Date
- SSY 05-14-2025
- ADTX 05-19-2025
- Dividend Yield
- SSY N/A
- ADTX N/A
- EPS Growth
- SSY N/A
- ADTX N/A
- EPS
- SSY 0.14
- ADTX N/A
- Revenue
- SSY $31,233,000.00
- ADTX $133,985.00
- Revenue This Year
- SSY N/A
- ADTX $95.61
- Revenue Next Year
- SSY N/A
- ADTX $1,584.79
- P/E Ratio
- SSY $7.25
- ADTX N/A
- Revenue Growth
- SSY N/A
- ADTX N/A
- 52 Week Low
- SSY $0.53
- ADTX $4.11
- 52 Week High
- SSY $1.91
- ADTX $35,000.00
- Technical
- Relative Strength Index (RSI)
- SSY 50.27
- ADTX 33.28
- Support Level
- SSY $0.97
- ADTX $4.17
- Resistance Level
- SSY $1.09
- ADTX $7.69
- Average True Range (ATR)
- SSY 0.08
- ADTX 1.92
- MACD
- SSY -0.00
- ADTX 0.36
- Stochastic Oscillator
- SSY 61.54
- ADTX 10.10
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.